MICHAEL POWELL - 14 Jun 2023 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Director
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Michael F. Powell
Issuer symbol
GRTX
Transactions as of
14 Jun 2023
Net transactions value
$0
Form type
4
Filing time
16 Jun 2023, 16:15:35 UTC
Previous filing
16 Jun 2022
Next filing
12 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +64,000 $0.000000 64,000 14 Jun 2023 Common Stock 64,000 $3.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.